Experiment 1179607
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | KELSEN,D: FLORE,J: HEELAN,R: CHENG,E: MAGILL,G:. (1987). PHASE II TRIAL OF ETOPOSIDE IN APUD TUMORS.. 71(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL,ETOPOSIDE WAS USED AS A SINGLE AGENT THERAPY FOR 33 PATIENTS WITH ADVANCED METASTATIC APUD TUMORS,(ISLET CELL,CARCINOID,OR MEDULLARY CARCINOMAS OF THE THYROID). THE DRUG WAS GIVEN ON DAYS 1,3 & 5,REPEAT EVERY 21 DAYS. IN 29 PATIENTS EVALUABLE FOR RESPONSE,4 PARTIAL RESPONSES WERE SEEN. TOXICITY INCLUDED NAUSEA,VOMITING AND MYELLOSUPPRESSION. THERE WERE NO TREATMENT RELATED DEATHS. |
| Dose amount | 150.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |